Advertisement

Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 338, Issue 5, pp 463–471 | Cite as

The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

  • S. Hjorth
  • T. Magnusson
Article

Summary

The present study was undertaken in an attempt to assess whether the effects of the potent and selective 5HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, on cerebral 5-hydroxytryptamine (5-HT) neurochemistry in vivo are mediated via 5-HT autoreceptors on the cell bodies or on the terminals, and/or via postsynaptic 5-HT receptors. To this end we determined in vivo indices of 5-HT synthesis and release/turnover rates in a number of prominent 5-HT neuronal projection areas in the CNS i) after systemic administration of 8-OH-DPAT to rats with an acute unilateral axotomy of the ascending mesencephalic monoamine neurones, or ii) after local infusion of the compound into the dorsal raphé (DRN) 5-HT cell body region of intact rats. Transection did not alter 5-HT synthesis per se, but prevented the synthesis-inhibitory effect of 8-OH-DPAT. Thus, the 5-HT synthesis-inhibiting action of 8-OH-DPAT is highly dependent upon intact impulse flow in the central 5-HT neurones. On the other hand, local DRN application of the compound (1 μg) resulted in a clearcut reduction of the 5-HT synthesis and release indices measured in 5-HT terminals in, e. g., the striatum. These findings provide direct neurochemical evidence that by preferentially stimulating somatodendritic 5-HT1A receptors, 8-OH-DPAT inhibits the 5-HT neuronal impulse flow, thereby effectuating decreased terminal 5-HT synthesis and release. Taken together, the data are consistent with the suggestion that 8-OH-DPAT acts as an agonist preferentially at cell body vs. terminal 5-HT autoreceptors, therefore also emphasizing the distinction between terminal and cell body 5-HT autoreceptors. The results obtained may have important implications for the understanding of mechanisms involved in regulating the activity of central serotoninergic neurones.

Key words

8-OH-DPAT [8-hydroxy-2-(di-n-propylamino)tetralin] 5-HT1A receptors CNS 5-HT synthesis and release Hemitransection Dorsal raphé application Regulation of 5-HT activity Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wikström H, Sanchez D, Arvidsson L-E, Hacksell U, Nilsson JLG (1981) Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav 15:785–792CrossRefGoogle Scholar
  2. Andén N-E (1980) Regulation of monoamine synthesis and utilization by receptors. In: Szekeres L (ed) Handbook of experimental pharmacology. Springer, Berlin Heidelberg New York, p 429Google Scholar
  3. Andén N-E, Fuxe K, Hökfelt T (1966) The importance of nervous impulse flow for the depletion of the monoamines from central neurons by some drugs. J Pharm Pharmacol 18:630–632CrossRefGoogle Scholar
  4. Arvidsson L-E, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H (1981) 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24:921–923CrossRefGoogle Scholar
  5. Baumann PA, Waldmeier PC (1981) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 317:36–43CrossRefGoogle Scholar
  6. Baumann PA, Waldmeier PC (1984) Negative feedback control of serotonin release in vivo: Comparison of 5-hydroxyindolacetic acid levels measured by voltammetry in conscious rats and by biochemical techniques. Neuroscience 11:195–204CrossRefGoogle Scholar
  7. Carlsson A, Lindqvist M (1978) Effect of reserpine on monoamine synthesis and on apparent dopaminergic receptor sensitivity in rat brain. In: Haber B, Aprison MH (eds) Neuropharmacology and behavior. Plenum Press, New York, pp 89–102CrossRefGoogle Scholar
  8. Carlsson A, Bédard P, Lindqvist M, Magnusson T (1972) The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Biochem Soc Symp 36:17–32Google Scholar
  9. Chaput Y, Blier P, de Montigny C (1986) In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals. J Neurosci 6:2796–2801CrossRefGoogle Scholar
  10. Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86:197–204CrossRefGoogle Scholar
  11. Dourish CT, Hutson PH, Curzon G (1986) Putative anxiolytics 8-OH-DPAT, buspirone and TVX Q 7821 are agonists at 5-HT1A autoreceptors in the raphe nuclei. TIPS 7:212–214Google Scholar
  12. Engel G, Göthert M, Hoyer D, Schlicker E, Hillenbrand K (1986) Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites. Naunyn-Schmiedeberg's Arch Pharmacol 332:1–7CrossRefGoogle Scholar
  13. Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368CrossRefGoogle Scholar
  14. Fallon SL, Kim HS, Welch JJ (1983) Electrophysiological evidence for modulation of dopamine neurons by 8-hydroxy-2-(di-n-propylamino)tetralin. Soc Neurosci Abstr 9:716Google Scholar
  15. Galloway MP, Novak EA, Mathews BN (1987) Characterization of synthesis-modulating serotonin (5-HT) autoreceptors in brain slices. Soc Neurosci Abstr 13:344 (No. 94.10)Google Scholar
  16. Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985) (3H)8-Hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685–1696CrossRefGoogle Scholar
  17. Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS (1984) Biochemical evidence for the 5-HT agonist properties of PAT [8-hydroxy-2-(di-n-propylamino)tetralin] in the rat brain. Eur J Pharmacol 100:263–276CrossRefGoogle Scholar
  18. Hassler R, Bak IJ (1969) Unbalanced ratios of striatal dopamine and serotonin after experimental interruption of strionigral connections in rat. In: Gillingham FG, Donaldson IML (eds) Third Symposium on Parkinson's Disease. Livingstone, London, pp 29–37Google Scholar
  19. Herr B, Roth RH (1976) The effect of acute raphe lesion on serotonin synthesis and metabolism in the rat forebrain and hippocampus. Brain Res 110:189–193CrossRefGoogle Scholar
  20. Hjorth S (1985) Hypothermia in the rat induced by the potent serotoninergic agent 8-OH-DPAT. J Neural Transm 60:131–135CrossRefGoogle Scholar
  21. Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55:169–188CrossRefGoogle Scholar
  22. Hjorth S, Carlsson A, Magnusson T, Arvidsson L-E (1987) In vivo biochemical characterization of 8-OH-DPAT — evidence for 5-HT receptor selectivity and agonist action in the rat CNS. In: Dourish CT, Ahlenius S, Hutson PH (eds) Brain 5-HT1A receptors: behavioural and neurochemical pharmacology, Health Science Series. Ellis Horwood Ltd, pp 94–105Google Scholar
  23. Kehr W (1974) Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy. J Neural Transm 35:307–317CrossRefGoogle Scholar
  24. Kehr W (1985) Receptor-mediated regulation of 5-hydroxytryptamine metabolism: current knowledge and open questions. Pharmacopsychiatry 18:193–197CrossRefGoogle Scholar
  25. Kehr W, Carlsson A, Lindqvist M (1977) Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol. Naunyn-Schmiedeberg's Arch Pharmacol 297:111–117CrossRefGoogle Scholar
  26. Magnusson O, Nilsson LB, Westerlund D (1980) Simultaneous determination of dopamine, dopac and homovanillic acid. Direct injection of supernatants from brain homogenates in a liquid chromatography-electrochemical detection system. J Chromatogr 221:237–247CrossRefGoogle Scholar
  27. Marcinkiewicz M, Verge D, Gozlan H, Pichat L, Hamon M (1984) Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res 291:159–163CrossRefGoogle Scholar
  28. Martin KF, Marsden CA (1987) Control of 5-HT metabolism in rat SCN — a primary role for terminal receptors? Br J Pharmacol 92:560PGoogle Scholar
  29. Middlemiss DN (1984) 8-Hydroxy-2-(di-n-propylamino)-tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the (3H)5-HT recognition site. Naunyn-Schmiedeberg's Arch Pharmacol 327:18–22CrossRefGoogle Scholar
  30. Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153CrossRefGoogle Scholar
  31. Mosko SS, Jacobs BL (1977) Electrophysiological evidence against negative neuronal feedback from the forebrain controlling midbrain raphé unit activity. Brain Res 119:291–303CrossRefGoogle Scholar
  32. Neale RF, Fallon SL, Boyar WC, Wasley JWF, Martin LL, Stone GA, Glaeser BS, Simon CM, Williams M (1987) Biochemical characterization of CGS 12066B, selective serotonin-1B agonist. Eur J Pharmacol 136:1–9CrossRefGoogle Scholar
  33. Neckers LM, Neff NH, Wyatt RJ (1979) Increased serotonin turnover in corpus striatum following an injection of kainic acid: Evidence for neuronal feedback regulation of synthesis. Naunyn-Schmiedeberg's Arch Pharmacol 306:173–177CrossRefGoogle Scholar
  34. Pettibone DJ, Pflueger BA (1984) Effects of methiothepin and lysergic acid diethylamide on serotonin release in vitro and serotonin synthesis in vivo: possible relation to serotonin autoreceptor function. J Neurochem 43:83–90CrossRefGoogle Scholar
  35. Shannon NJ, Gunnet JW, Moore KE (1986) A comparison of biochemical indices of 5-hydroxytryptaminergic neuronal activity following electrical stimulation of the dorsal raphe nucleus. J Neurochem 47:958–965CrossRefGoogle Scholar
  36. Sharp T, Bramwell S, Maskell L, Grahame-Smith DG (1988) 5-HT1 agonists reduce 5-HT release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 93:94PGoogle Scholar
  37. Shum A, Sole MJ, Van Loon GR (1982) Simultaneous measurement of 5-hydroxytryptophan and l-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical detection. Measurement of serotonin and catecholamine turnover in discrete brain regions. J Chromatogr 228:123–130CrossRefGoogle Scholar
  38. Söderpalm B, Hjorth S, Engel JA (1988) Effects of 5-HT1A agonists and L-5-HTP in Montgomery's conflict test. Pharmacol Biochem Behav (in press)Google Scholar
  39. Soubrié P, Reisine TD, Glowinski J (1984) Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience 13:605–625CrossRefGoogle Scholar
  40. Sprouse JS, Aghajanian GK (1986) (−)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HTIA selective agents. Eur J Pharmacol 128:295–298CrossRefGoogle Scholar
  41. Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of hippocampal pyramidal cells to serotonin 5-HT-1A and 5-HT-1B selective agonists: a comparative study with dorsal raphé neurons. Soc Neurosci Abstr 13:1650 (No. 459.9)Google Scholar
  42. de St. Hilaire-Kafi S, Hjorth S, Gaillard JM (1987) Effects of 8-OH-DPAT on the sleep-waking cycle in the rat. In: Dourish CT, Ahlenius S, Huston PH (eds) Brain 5-HTIA receptors: behavioural and neurochemical pharmacology, Health Science Series. Ellis Horwood Ltd, pp 135–139Google Scholar
  43. Tricklebank M, Forler C, Fozard JR (1984) The involvement of subtypes of the 5-HT1 receptor and of catecholammergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmacol 106:271–282CrossRefGoogle Scholar
  44. Wagner J, Vitali P, Palfreyman MG, Zraika M, Huot S (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanine, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin, and 5-hydroxyindoleacetic acid in rat cerebrospinal fluid and brain by high-performance liquid chromatography with electrochemical detection. J Neurochem 38:1241–1254CrossRefGoogle Scholar
  45. Walters JR, Roth RH (1976) Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 296:5–14CrossRefGoogle Scholar
  46. Weissman-Nanopoulos D, Mach E, Magre J, Demassey Y, Pujol J-F (1985) Evidence for the localization of 5-HTIA binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 7:1061–1072CrossRefGoogle Scholar
  47. Vergé D, Daval G, Patey A, Gozlan H, El Mestikawy S, Hamon M (1985) Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype. Eur J Pharmacol 113:463–464CrossRefGoogle Scholar
  48. Vergé D, Daval G, Marcinkiewicz M, Patey A, El Mestikawy S, Gozlan H, Hamon M (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474–3482CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1988

Authors and Affiliations

  • S. Hjorth
    • 1
  • T. Magnusson
    • 1
  1. 1.Department of PharmacologyUniversity of GöteborgGöteborgSweden

Personalised recommendations